SUBSCRIBE
SUBSCRIBE

Phase 1

3 Biotechs That Could be Taken Out This Quarter
Drug Development
2 Tiny Cancer Biotechs That Could Gain Steam by Year-End
July 24, 2017
 · 
3 min read
10 Biotechs Tackling Senator John McCain's Form of Aggressive Brain Cancer
Drug Development
10 Biotechs Tackling Senator John McCain’s Form of Aggressive Brain Cancer
July 21, 2017
 · 
3 min read
Kite Pharma's CAR-T Blood Cancer Candidate Succeeds in Major Study
Drug Development
Kite Pharma Touts Remissions Up to 56+ Months in Non-Hodgkin Lymphoma Patients on CAR T-Cell Therapy
July 20, 2017
 · 
3 min read
Roche Slammed With Partial Holds for Two Combo Cancer Trials
Drug Development
Uncertainty Hits as Roche is Dealt Multiple Clinical Trial Setbacks
July 19, 2017
 · 
3 min read
Why Booming Vertex is on Its Way to Becoming Gilead's Mini-Me
Drug Development
Vertex Gains $8 Billion Overnight as Cystic Fibrosis Combo Drug Wows in Trials
July 19, 2017
 · 
3 min read
FDA Approval of Siliq for Psoriasis – How Will the Drug Perform in an Already Overcrowded Market?
Drug Development
Samsung Bioepis Emerging as a Strong Player in the Autoimmune Space
July 18, 2017
 · 
3 min read
3 Biotechs That Could be Taken Out This Quarter
Drug Development
How Much Money Will These 5 Pharma Companies’ Pipelines Generate in 5 Years
July 18, 2017
 · 
3 min read
Drug Development
Why Biogen Spinoff Bioverativ’s Anemia Drug Could Be A Blockbuster
July 11, 2017
 · 
1 min read
Let's Get Rid Of Clinical Trials - Part 2
BioMidwest
BioPharm Executive: And So It Continues: Let’s Get Rid of Clinical Trials (Part 2)
July 7, 2017
 · 
4 min read
What You Missed: Nippon Fine Chemical Formed Human Barricade to Stop FDA Employee
Drug Development
Mark Your Calendars: 7 Biotechs Facing Important Catalysts in July
July 6, 2017
 · 
3 min read
Load More
PRESS RELEASES
Press Releases
Prokarium Reports Positive Interim Data from Phase 1/1b PARADIGM-1 trial of ZH9 in NMIBC patients, Demonstrating Excellent Safety and Encouraging Early Efficacy
May 18, 2026
 · 
2 min read
Press Releases
Design Therapeutics to Host Investor Webcast to Review Data from RESTORE-FA Trial of DT-216P2 for Friedreich’s Ataxia on Monday, May 18, 2026
May 17, 2026
 · 
1 min read
Press Releases
Agenus Announces Publication of Phase 1b Botensilimab and Balstilimab Data in Post-Immunotherapy Hepatocellular Carcinoma in Liver Cancer
May 17, 2026
 · 
9 min read
Press Releases
Atisama Therapeutics Advances RB042 into Multiple Ascending Dose cohorts of Phase 1 Trial and Appoints Bernard Coulie as Chair of the Board
May 17, 2026
 · 
4 min read
Press Releases
Positive Interim Data from Cohorts 1 and 2 of Tenaya’s RIDGE™-1 Phase 1b/2 Clinical Trial of TN-401 Demonstrated Consistent Reductions in Arrhythmia Burden for Adults with PKP2-associated ARVC
May 15, 2026
 · 
13 min read
Press Releases
SN BioScience Doses First Patient in Phase 1b/2 Clinical Trial of ‘SNB-101'
May 14, 2026
 · 
2 min read
Press Releases
Nurix Therapeutics Presents New Preclinical and Phase 1 Translational Data Supporting Bexobrutideg (NX-5948) in Chronic Spontaneous Urticaria at the 2026 Society for Investigative Dermatology Annual Meeting
May 14, 2026
 · 
7 min read
Press Releases
Imviva Biotech Presents Data Demonstrating Durable Clinical Responses from Ongoing Phase 1/2 Study of CTA313 in Systemic Lupus Erythematosus at ASGCT 2026
May 14, 2026
 · 
3 min read
Press Releases
Senti Biosciences Holdings Announces Positive FDA RMAT Meeting on Registrational Clinical and CMC Strategy for SENTI-202 in Relapsed/Refractory AML, Along with Important Efficacy and Durability Updates on the SENTI-202 Clinical Program
May 14, 2026
 · 
11 min read
Press Releases
MIRA Pharmaceuticals Reports Positive Unblinded Phase 1 Data for Ketamir-2
May 14, 2026
 · 
6 min read
Press Releases
Forward Therapeutics Announces Completion of Phase 1 Trials with Two Internally Discovered Next-Generation TNF Signaling Inhibitors Supporting Advancement to Phase 2 Clinical Development
May 14, 2026
 · 
3 min read
Press Releases
Corvus Pharmaceuticals Presents Soquelitinib Phase 1 Atopic Dermatitis Data at the Society for Investigative Dermatology (SID) Annual Meeting
May 14, 2026
 · 
18 min read
Press Releases
Climb Bio to Present New Budoprutug Clinical Data at European Hematology Association (EHA) 2026 Congress
May 14, 2026
 · 
5 min read
Press Releases
Vivani Medical Reports First Quarter 2026 Financial Results and Provides Business Update
May 14, 2026
 · 
11 min read
Press Releases
Tango Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Highlights
May 14, 2026
 · 
10 min read
Press Releases
Encoded Therapeutics Presents New Clinical Data from POLARIS Phase 1/2 Trials of ETX101 Gene Therapy in Dravet Syndrome at the ASGCT 2026 Presidential Symposium
May 13, 2026
 · 
6 min read
Press Releases
Sapu Nano Announces First Patient Dosed in Phase 1b Trial of Sapu003, an Intravenous Deciparticle™ Formulation of Everolimus
May 13, 2026
 · 
2 min read
Press Releases
InnoCare Announce First Subject Dosed in Phase 1 Clinical Trial of ICP-054, a Novel Potentially Best-in-Class Oral IL-17AA/AF Inhibitor
May 13, 2026
 · 
4 min read
Press Releases
First-in-Class Oral PKM2 Modulator SYX-5219 Phase 1a Trial Data to be Presented at SID 2026
May 13, 2026
 · 
4 min read
Press Releases
Zenas BioPharma Announces First Subject Dosed in Phase 1 Clinical Trial of ZB021, a Novel, Potentially Best-in-Class Oral IL-17AA/AF Inhibitor
May 13, 2026
 · 
11 min read
Load More